CD34 and congenital dyserythropoietic anemia: In the developing world with limited resources and financial constraint, severe case of CDA can be managed successfully with allogeneic HSCT by using myeloablative conditioning regimen, infusing high CD34+ stem cell dose, to ensure early engraftment; appropriate and adequate GVHD measure would contribute to reducing infection rate and duration of hospital stay.